Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma.
Tao L, Miao R, Mekhail T, Sun J, Meng L, Fang C, Guan J, Jain A, Du Y, Allen A, Rzeszutko BL, Socinski MA, Chang CC.
Tao L, et al. Among authors: jain a.
Clin Lung Cancer. 2021 Jul;22(4):e506-e511. doi: 10.1016/j.cllc.2020.07.004. Epub 2020 Jul 15.
Clin Lung Cancer. 2021.
PMID: 32807653